Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (41-50 of 399) with videos related to

Pageof 40
Sort By:
Gastroenterology|March 1, 2016
Extracellular Vesicles as Messengers Between Hepatocytes and Macrophages in Nonalcoholic SteatohepatitisJörn M Schattenberg, Myung-Shik Lee
Zeitschrift Fur Gastroenterologie|July 14, 2015
[Overt hepatic encephalopathy: extension of therapeutic armamentarium by old friends?]M Nguyen-Tat, J M Schattenberg
Clinical Interventions in Aging|September 22, 2021
NAFLD in the ElderlySaleh A Alqahtani, Jörn M Schattenberg
Journal of Hepatology|July 14, 2009
Show me your signaling--and I'll tell you who you areJörn M Schattenberg, Peter R Galle
Gastroenterology|April 18, 2020
Nonalcoholic Fatty Liver Disease in 2020Jacquelyn J Maher, Jörn M Schattenberg
Expert Review of Molecular Diagnostics|August 4, 2021
Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practiceSaleh A Alqahtani, Jörn M Schattenberg
United European Gastroenterology Journal|May 14, 2022
The unmet need of personalized HCC screening-Lessons learned from the Swedish nationwide registriesSimon Johannes Gairing, Jörn M Schattenberg
United European Gastroenterology Journal|May 27, 2020
Liver injury in COVID-19: The current evidenceSaleh A Alqahtani, Jörn M Schattenberg
Redox Biology|December 3, 2014
Regulation of the effects of CYP2E1-induced oxidative stress by JNK signalingJörn M Schattenberg, Mark J Czaja
JHEP Reports : Innovation in Hepatology|July 11, 2026
The Use of FGF21 Analogues in MASH and MASH Cirrhosis - Metabolic Master Regulators or Liver-Specific Mechanisms? <sup>☆</sup>A G Holleboom, J M Schattenberg
Pageof 40

Showing results (41-50 of 399) with videos related to

Sort By:
Pageof 40
Gastroenterology|March 1, 2016
Extracellular Vesicles as Messengers Between Hepatocytes and Macrophages in Nonalcoholic SteatohepatitisJörn M Schattenberg, Myung-Shik Lee
Zeitschrift Fur Gastroenterologie|July 14, 2015
[Overt hepatic encephalopathy: extension of therapeutic armamentarium by old friends?]M Nguyen-Tat, J M Schattenberg
Clinical Interventions in Aging|September 22, 2021
NAFLD in the ElderlySaleh A Alqahtani, Jörn M Schattenberg
Journal of Hepatology|July 14, 2009
Show me your signaling--and I'll tell you who you areJörn M Schattenberg, Peter R Galle
Gastroenterology|April 18, 2020
Nonalcoholic Fatty Liver Disease in 2020Jacquelyn J Maher, Jörn M Schattenberg
Expert Review of Molecular Diagnostics|August 4, 2021
Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practiceSaleh A Alqahtani, Jörn M Schattenberg
United European Gastroenterology Journal|May 14, 2022
The unmet need of personalized HCC screening-Lessons learned from the Swedish nationwide registriesSimon Johannes Gairing, Jörn M Schattenberg
United European Gastroenterology Journal|May 27, 2020
Liver injury in COVID-19: The current evidenceSaleh A Alqahtani, Jörn M Schattenberg
Redox Biology|December 3, 2014
Regulation of the effects of CYP2E1-induced oxidative stress by JNK signalingJörn M Schattenberg, Mark J Czaja
JHEP Reports : Innovation in Hepatology|July 11, 2026
The Use of FGF21 Analogues in MASH and MASH Cirrhosis - Metabolic Master Regulators or Liver-Specific Mechanisms? <sup>☆</sup>A G Holleboom, J M Schattenberg
Pageof 40